Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01931204

Ligand	Ligand name	Chain	PDB	Tanimoto
DEO		A,B	1ROS	0.73
SP6	BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE	A,B	2OW9	0.7
903	2-{4-[2-ACETYLAMINO-2-(1-BIPHENYL-4-YLMETHYL-2-OXO-AZEPAN-3-YLCARBAMOYL)-ETHYL]-2-METHOXYCARBONYL-PHENYL}-2-FLUORO-MALONIC ACID	A	1O46	0.71
IFA		A,B	3FC8	0.71
BCG	3-(BENZOYLOXY)-8-METHYL-8-AZABICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID	H	1QYG	0.71
IFB	N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINE	A,B	3FCB	0.7
TNK	6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL	A	1JLA	0.71
TNK	6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL	A	1RT2	0.71
TNK	6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL	A	1S1V	0.71
F59	N-[(biphenyl-4-ylcarbonyl)carbamoyl]-beta-D-glucopyranosylamine	A	2QLN	0.7
HOP	(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL	H,L	1D6V	0.74
HOP	(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL	A,B,H,L	1AXS	0.74
197	4-[2-ACETYLAMINO-2-(1-BIPHENYL-4-YLMETHYL-2-OXO-AZEPAN-3-YLCARBAMOYL)-ETHYL]-2-FORMYL-BENZOIC ACID	A	1O4A	0.71
BJP	(1R)-2-PHENYLACETAMIDO-2-(3-CARBOXYPHENYL)ETHYL BORONIC ACID	A	1ERO	0.7
CS7	N'-[(1S,2R)-2-[(2R,4R)-4-(BENZYLOXY)PYRROLIDIN-2-YL]-1-(3,5-DIFLUOROBENZYL)-2-HYDROXYETHYL]-5-METHYL-N,N-DIPROPYLISOPHTHALAMIDE	A,B	2QMD	0.72
WH6	2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid	A,B	2R9X	0.7
UBC	(S)-1-(2-AMINO-2-CARBOXYETHYL)-3-(2-CARBOXYBENZYL)PYRIMIDINE-2,4-DIONE	A,B	2F35	0.72
VBP	4-({3-[(2R)-2-amino-2-carboxyethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}methyl)benzoic acid	B,E,G,H,J,L,N,P	3H06	0.71
GR1	6-CARBAMIMIDOYL-2-[5-(3-DIETHYLCARBAMOYL-PHENYL)-2-HYDROXY-INDAN-1-YL]-HEXANOIC ACID	B,I	1QJ7	0.73
COC	COCAINE	A,C	1I7Z	0.73
COC	COCAINE	H	1Q72	0.73
COC	COCAINE	L	2AJV	0.73
COC	COCAINE	A,B,C,D,E	2PGZ	0.73
KEU	N-{4-[(1R)-4-[(2R,4R,5S)-2,4-DIAMINO-6-OXOHEXAHYDROPYRIMIDIN-5-YL]-1-(2,2,2-TRIFLUORO-1,1-DIHYDROXYETHYL)BUTYL]BENZOYL}-D-GLUTAMIC ACID	A,B	1NJS	0.7
KEU	N-{4-[(1R)-4-[(2R,4R,5S)-2,4-DIAMINO-6-OXOHEXAHYDROPYRIMIDIN-5-YL]-1-(2,2,2-TRIFLUORO-1,1-DIHYDROXYETHYL)BUTYL]BENZOYL}-D-GLUTAMIC ACID	A,B,C,D	1RBY	0.7
KEU	N-{4-[(1R)-4-[(2R,4R,5S)-2,4-DIAMINO-6-OXOHEXAHYDROPYRIMIDIN-5-YL]-1-(2,2,2-TRIFLUORO-1,1-DIHYDROXYETHYL)BUTYL]BENZOYL}-D-GLUTAMIC ACID	A,B,C,D	1RBQ	0.7
2T1	2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid	A,B	3FMZ	0.72
XIN	methyl (3Z)-3-{[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}phenyl)amino](phenyl)methylidene}-2-oxo-2,3-dihydro-1H-indole-6-carboxylate	A	3C7Q	0.71
RBE	3-(BENZOYLOXY)-8-AZA-BICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID	H	1RIU	0.74